Population Qualitative Data

Population age groups

  • Paediatric Population (< 18 years)
    • Neonate
      • Preterm newborn infants (0 – 27 days)
      • Term newborn infants (0 – 27 days)
    • Infants and toddlers (28 days – 23 months)
    • Adolescents (12 to < 18 years)
  • Adult and elderly population (≥18 years)
    • Adults (18 to < 65 years)
      • Adults (18 to < 46 years)
      • Adults (46 to < 65 years)

Estimated percentage of the population covered by the data source in the catchment area

This varies between countries ranging from a few up to approximately 25%. Regarding the quantitative descriptors by age, the primary objective of the EURAP study is to assess the prevalence of major congenital malformations in offspring exposed to antiseizure medication, with a follow-up until one year after birth.

Description of the population covered by the data source in the catchment area whose data are not collected (e.g., people who are registered only for private care)

Regional sub-set - Those under treatment by physicians that are not participating in the EURAP network
Family linkage

Family linkage available in the data source permanently or can be created on an ad hoc basis

Permanently

Family linkage available between the following persons

Mother-child
Sibling
Population

Population size

23400

Active population size

1585
Median observation time

Median time (years) between first and last available records for unique individuals

2.00

Median time (years) between first and last available records for unique active individuals (alive and currently registered)

1.00